Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones (original) (raw)

• Armstrong JS . (2007). Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 151: 1154–1165.
  Article CAS PubMed PubMed Central Google Scholar
• Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA et al. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434: 658–662.
  Article CAS PubMed Google Scholar
• Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD . (2007). Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9: 550–555.
  Article CAS PubMed PubMed Central Google Scholar
• Barral JM, Hutagalung AH, Brinker A, Hartl FU, Epstein HF . (2002). Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin. Science 295: 669–671.
  Article CAS PubMed Google Scholar
• Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T et al. (2000). Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2: 469–475.
  Article CAS PubMed Google Scholar
• Butcher EC . (2005). Can cell systems biology rescue drug discovery? Nat Rev Drug Discov 4: 461–467.
  Article CAS PubMed Google Scholar
• Cechetto JD, Gupta RS . (2000). Immunoelectron microscopy provides evidence that tumor necrosis factor receptor-associated protein 1 (TRAP-1) is a mitochondrial protein which also localizes at specific extramitochondrial sites. Exp Cell Res 260: 30–39.
  Article CAS PubMed Google Scholar
• Chen LB . (1988). Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 4: 155–181.
  Article CAS PubMed Google Scholar
• Citri A, Yarden Y . (2006). EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7: 505–516.
  Article CAS PubMed Google Scholar
• Cowen LE, Lindquist S . (2005). Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309: 2185–2189.
  Article CAS PubMed Google Scholar
• Dai C, Whitesell L, Rogers AB, Lindquist S . (2007). Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 130: 1005–1018.
  Article CAS PubMed PubMed Central Google Scholar
• Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A . (2007). BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 12: 171–185.
  Article CAS PubMed Google Scholar
• Drysdale MJ, Brough PA, Massey A, Jensen MR, Schoepfer J . (2006). Targeting Hsp90 for the treatment of cancer. Curr Opin Drug Discov Devel 9: 483–495.
  CAS PubMed Google Scholar
• Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM et al. (2008). Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 14: 1097–1105.
  Article CAS PubMed PubMed Central Google Scholar
• Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, Zehetmeier C et al. (2004). Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 6: 507–514.
  Article CAS PubMed Google Scholar
• Fantin VR, Leder P . (2006). Mitochondriotoxic compounds for cancer therapy. Oncogene 25: 4787–4797.
  Article CAS PubMed Google Scholar
• Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO . (2000). The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275: 3305–3312.
  Article CAS PubMed Google Scholar
• Fernandez-Carneado J, Van Gool M, Martos V, Castel S, Prados P, de Mendoza J et al. (2005). Highly efficient, nonpeptidic oligoguanidinium vectors that selectively internalize into mitochondria. J Am Chem Soc 127: 869–874.
  Article CAS PubMed Google Scholar
• Forte M, Gold BG, Marracci G, Chaudhary P, Basso E, Johnsen D et al. (2007). Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proc Natl Acad Sci 104: 7558–7563.
  Article CAS PubMed PubMed Central Google Scholar
• Freeman BC, Yamamoto KR . (2002). Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296: 2232–2235.
  Article CAS PubMed Google Scholar
• Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A et al. (1998). Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821–824.
  Article CAS PubMed Google Scholar
• Green DR, Kroemer G . (2004). The pathophysiology of mitochondrial cell death. Science 305: 626–629.
  Article CAS PubMed Google Scholar
• Gyurkocza B, Plescia J, Raskett CM, Garlick DS, Lowry PA, Carter BZ et al. (2006). Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors. J Natl Cancer Inst 98: 1068–1077.
  Article CAS PubMed Google Scholar
• Halestrap AP . (2009). What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46: 821–831.
  Article CAS PubMed Google Scholar
• He L, Lemasters JJ . (2002). Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett 512: 1–7.
  Article CAS PubMed Google Scholar
• Henchcliffe C, Beal MF . (2008). Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 4: 600–609.
  Article CAS PubMed Google Scholar
• Hua G, Zhang Q, Fan Z . (2007). Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J Biol Chem 282: 20553–20560.
  Article CAS PubMed Google Scholar
• Igney FH, Krammer PH . (2002). Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2: 277–288.
  Article CAS PubMed Google Scholar
• Isaacs JS, Xu W, Neckers L . (2003). Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3: 213–217.
  Article CAS PubMed Google Scholar
• Johnstone RW, Ruefli AA, Lowe SW . (2002). Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153–164.
  Article CAS PubMed Google Scholar
• Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC et al. (2003). A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425: 407–410.
  Article CAS PubMed Google Scholar
• Kang BH, Plescia J, Dohi T, Rosa J, Doxsey SJ, Altieri DC . (2007). Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 131: 257–270.
  Article CAS PubMed Google Scholar
• Kang BH, Plescia J, Song HY, Meli M, Colombo G, Beebe K et al. (2009). Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. J Clin Invest 119: 454–464.
  Article CAS PubMed PubMed Central Google Scholar
• Koga F, Xu W, Karpova TS, McNally JG, Baron R, Neckers L . (2006). Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. Proc Natl Acad Sci USA 103: 11318–11322.
  Article CAS PubMed PubMed Central Google Scholar
• Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP et al. (2004). The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427: 461–465.
  Article CAS PubMed PubMed Central Google Scholar
• Kolata G . (2009). In long drive to cure cancer, advances have been elusive. The New York Times. April 24 Health Section.
• Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ et al. (2006). The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313: 1929–1935.
  Article CAS PubMed Google Scholar
• Leaf C . (2004). Why we’re losing the war on cancer (and how to win it). Fortune 149: 76–97.
  PubMed Google Scholar
• Li R, Boehm AL, Miranda MB, Shangary S, Grandis JR, Johnson DE . (2007). Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells. Neoplasia 9: 801–811.
  Article CAS PubMed PubMed Central Google Scholar
• MacKeigan JP, Murphy LO, Blenis J . (2005). Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7: 591–600.
  Article CAS PubMed Google Scholar
• Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, Nakajo S et al. (2004). Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J Biol Chem 279: 42503–42515.
  Article CAS PubMed Google Scholar
• McClellan AJ, Xia Y, Deutschbauer AM, Davis RW, Gerstein M, Frydman J . (2007). Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell 131: 121–135.
  Article CAS PubMed Google Scholar
• Montesano Gesualdi N, Chirico G, Pirozzi G, Costantino E, Landriscina M, Esposito F . (2007). Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress 10: 342–350.
  Article CAS PubMed Google Scholar
• Mootha VK, Bunkenborg J, Olsen JV, Hjerrild M, Wisniewski JR, Stahl E et al. (2003). Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115: 629–640.
  Article CAS PubMed Google Scholar
• Murphy MP . (2008). Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 1777: 1028–1031.
  Article CAS PubMed Google Scholar
• Nakagawa T, Shimizu S, Watanabe T, Yamaguchi O, Otsu K, Yamagata H et al. (2005). Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434: 652–658.
  Article CAS PubMed Google Scholar
• Neckers L . (2002). Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 8: S55–S61.
  Article CAS PubMed Google Scholar
• O’Dwyer ME, Druker BJ . (2000). STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia. Lancet Oncol 1: 207–211.
  Article PubMed Google Scholar
• Pearl LH, Prodromou C . (2000). Structure and in vivo function of Hsp90. Curr Opin Struct Biol 10: 46–51.
  Article CAS PubMed Google Scholar
• Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, Scheid M et al. (2005). Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem 280: 34025–34032.
  Article CAS PubMed Google Scholar
• Pilkington GJ, Parker K, Murray SA . (2008). Approaches to mitochondrially mediated cancer therapy. Semin Cancer Biol 18: 226–235.
  Article CAS PubMed Google Scholar
• Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG et al. (2005). Rational design of shepherdin, a novel anticancer agent. Cancer Cell 7: 457–468.
  Article CAS PubMed Google Scholar
• Price JT, Quinn JM, Sims NA, Vieusseux J, Waldeck K, Docherty SE et al. (2005). The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res 65: 4929–4938.
  Article CAS PubMed Google Scholar
• Pridgeon JW, Olzmann JA, Chin LS, Li L . (2007). PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5: e172.
  Article PubMed PubMed Central Google Scholar
• Prodromou C, Roe SM, O’Brien R, Ladbury JE, Piper PW, Pearl LH . (1997). Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90: 65–75.
  Article CAS PubMed Google Scholar
• Rajasethupathy P, Vayttaden SJ, Bhalla US . (2005). Systems modeling: a pathway to drug discovery. Curr Opin Chem Biol 9: 400–406.
  Article CAS PubMed Google Scholar
• Rodina A, Vilenchik M, Moulick K, Aguirre J, Kim J, Chiang A et al. (2007). Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. Nat Chem Biol 3: 498–507.
  Article CAS PubMed Google Scholar
• Ross MF, Filipovska A, Smith RA, Gait MJ, Murphy MP . (2004). Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers. Biochem J 383: 457–468.
  Article CAS PubMed PubMed Central Google Scholar
• Sawyers C . (2004). Targeted cancer therapy. Nature 432: 294–297.
  Article CAS PubMed Google Scholar
• Schein PS, Scheffler B . (2006). Barriers to efficient development of cancer therapeutics. Clin Cancer Res 12: 3243–3248.
  Article CAS PubMed Google Scholar
• Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J et al. (2005). Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 102: 12005–12010.
  Article CAS PubMed PubMed Central Google Scholar
• Schmid D, Baici H, Gehring H, Christen P . (1994). Kinetics of molecular chaperon action. Science 263: 971–973.
  Article CAS PubMed Google Scholar
• Solit DB, Chiosis G . (2008). Development and application of Hsp90 inhibitors. Drug Discov Today 13: 38–43.
  Article CAS PubMed Google Scholar
• Steensma DP . (2009). The ordinary miracle of cancer clinical trials. J Clin Oncol 27: 1737–1739.
  Article PubMed Google Scholar
• Szeto HH . (2008). Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases. Ann NY Acad Sci 1147: 112–121.
  Article CAS PubMed Google Scholar
• Torchilin VP . (2006). Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 8: 343–375.
  Article CAS PubMed Google Scholar
• Tsujimoto Y, Shimizu S . (2007). Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12: 835–840.
  Article CAS PubMed Google Scholar
• van der Greef J, McBurney RN . (2005). Innovation: rescuing drug discovery: in vivo systems pathology and systems pharmacology. Nat Rev Drug Discov 4: 961–967.
  Article CAS PubMed Google Scholar
• Vogelstein B, Kinzler KW . (2004). Cancer genes and the pathways they control. Nat Med 10: 789–799.
  Article CAS PubMed Google Scholar
• Vogler M, Dinsdale D, Dyer MJS, Cohen GM . (2008). Bcl-2 inhibitors: small molecules with a big impact on cancer therapy. Cell Death Differ 16: 360–367.
  Article PubMed Google Scholar
• Voloboueva LA, Duan M, Ouyang Y, Emery JF, Stoy C, Giffard RG . (2007). Overexpression of mitochondrial Hsp70//Hsp75 protects astrocytes against ischemic injury in vitro. J Cereb Blood Flow Metab 28: 1009–1016.
  Article PubMed Google Scholar
• Weinstein IB, Joe AK . (2006). Mechanisms of disease: oncogene addiction—a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol 3: 448–457.
  Article CAS PubMed Google Scholar
• Whitesell L, Lindquist SL . (2005). HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761–772.
  Article CAS PubMed Google Scholar
• Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science 318: 1108–1113.
  Article CAS PubMed Google Scholar
• Woodfield K, Ruck A, Brdiczka D, Halestrap AP . (1998). Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J 336 (Pt 2): 287–290.
  Article CAS PubMed PubMed Central Google Scholar
• Wright GL, Maroulakou IG, Eldridge J, Liby TL, Sridharan V, Tsichlis PN et al. (2008). VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase. FASEB J 22: 3264–3275.
  Article CAS PubMed PubMed Central Google Scholar
• Xu L, Voloboueva LA, Ouyang Y, Emery JF, Giffard RG . (2008). Overexpression of mitochondrial Hsp70//Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab 29: 365–374.
  Article PubMed Google Scholar
• Young JC, Hoogenraad NJ, Hartl FU . (2003). Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 112: 41–50.
  Article CAS PubMed Google Scholar
• Young JC, Moarefi I, Hartl FU . (2001). Hsp90: a specialized but essential protein-folding tool. J Cell Biol 154: 267–273.
  Article CAS PubMed PubMed Central Google Scholar
• Zeitlin BD, Zeitlin IJ, Nor JE . (2008). Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents. J Clin Oncol 26: 4180–4188.
  Article CAS PubMed PubMed Central Google Scholar
• Zhao R, Houry WA . (2007). Molecular interaction network of the Hsp90 chaperone system. Adv Exp Med Biol 594: 27–36.
  Article PubMed Google Scholar